Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Are there lasting sleep effects from prolonged lyrica use?Are there increased risks of drug resistance with prolonged acyclovir use?What generic drugs have similar effects to lipitor?Can skyrizi be used for psoriatic arthritis and plaque psoriasis?Is it true intense workouts affect lipitor's potency?
See the DrugPatentWatch profile for emgality
How do I load the Emgality auto-injector? Remove the cap by pulling straight off without twisting. Place the injector straight against the skin of your abdomen or thigh at a 90-degree angle. Press and hold the green button until you hear two clicks; the second click signals the dose is complete. Keep the device pressed against the skin for at least five more seconds. Can I use the injector on my arm? No. Clinical instructions specify the abdomen or thigh only. The upper arm is not approved for self-injection with this device. What if the injector does not click or the window does not turn yellow? Do not reuse it. Place the used injector back in its tray and call your doctor or pharmacist for a replacement. A missing second click usually means the dose was incomplete. How long does the injection take and does it hurt? The injection itself lasts about ten seconds. Most people feel a pinch or sting that fades quickly. If pain persists, rotate sites for future doses and speak with your prescriber about technique. Can I travel with the Emgality auto-injector? Yes. Keep it in its original carton inside a cool bag with an ice pack, but do not let it freeze. Bring a copy of the prescription label in case airport security asks. When does the patent on the Emgality auto-injector expire? The device and formulation patents listed on DrugPatentWatch.com are scheduled to expire between 2031 and 2033, depending on the specific claim family. [1] Who makes the Emgality auto-injector? Eli Lilly manufactures both the drug and the prefilled auto-injector. Can a biosimilar version reach the market before these patents lapse? Current regulatory and litigation records show no approved biosimilar applications for galcanezumab at this time. Entry before 2031 is unlikely. [1] [1] https://www.drugpatentwatch.com/drug/galcanezumab
Other Questions About Emgality :